Results 11 to 20 of about 1,643,766 (139)

Factors that affect the onset of action of non-depolarizing neuromuscular blocking agents [PDF]

open access: yesKorean Journal of Anesthesiology, 2017
Neuromuscular blockade plays an important role in the safe management of patient airways, surgical field improvement, and respiratory care. Rapid-sequence induction of anesthesia is indispensable to emergency surgery and obstetric anesthesia, and its ...
Yong Byum Kim   +2 more
doaj   +5 more sources

Resistance to non-depolarizing neuromuscular blocking agents [PDF]

open access: yesAsian Pacific Journal of Health Sciences, 2020
The authors experienced three cases of the resistance to the nondepolarizing neuromuscular blocking agents (NMBAs), rocuronium. There are many factors that affect NMBAs such as steroid, endocrine or autoimmune diseases which are thyroid disease ...
Dong-Min Hyun   +4 more
core   +2 more sources

Neuromuscular blockade management for intraoperative neural monitoring

open access: yesKaohsiung Journal of Medical Sciences, 2020
This article reviews the literature on development of neuromuscular blockade management in thyroid surgery with intraoperative neural monitoring (IONM) in the past decade.
I‐Cheng Lu   +2 more
doaj   +2 more sources

The effect of non-depolarizing neuromuscular blocking agents on the release of acetylcholine from the right atrium of the guinea pig [PDF]

open access: yesActa medica Okayama, 1997
The effect of various non-depolarizing neuromuscular blocking agents (gallamine, pancuronium, vecuronium, d-tubocurarine, metocurine, atracurium and pipecuronium) on [3H] acetylcholine release in the response to field electrical stimulation was ...
Manabe, Nobuki
core   +4 more sources

Use and Outcomes of Sugammadex for Neurological Examination after Neuromuscular Blockade in the Emergency Department [PDF]

open access: yesWestern Journal of Emergency Medicine
Introduction: Non-depolarizing agents such as rocuronium and vecuronium are frequently used in the emergency department (ED) to facilitate intubation but may lead to delay in neurologic examination and intervention.
Stephen D. Hallisey   +4 more
doaj   +2 more sources

Erratum: Factors that affect the onset of action of non-depolarizing neuromuscular blocking agents [PDF]

open access: yesKorean Journal of Anesthesiology, 2017
[This corrects the article on p. 500 in vol. 70, PMID: 29046769.].
Yong Beom Kim   +2 more
doaj   +3 more sources

The association between non-depolarizing neuromuscular blockade agents and survival to discharge in dogs undergoing mechanical ventilation: a multi-center retrospective study of 227 dogs (2010–2020)

open access: yesFrontiers in Veterinary Science
ObjectiveTo evaluate the association between neuromuscular blockade agent (NMBA) use and outcome in dogs undergoing mechanical ventilation (MV), including survival to discharge, and complications.MethodsThe medical records for 227 mechanically ventilated
Lena Ngo   +9 more
doaj   +3 more sources

Sugammadex administration in patients with end-stage renal disease: a narrative review with recommendations [PDF]

open access: yesAnesthesia and Pain Medicine, 2023
Due to unknown safety concerns, sugammadex should not be administered to patients with end-stage renal disease (ESRD). However, because the supply of benzylisoquinolinium-type neuromuscular blocking agents (NMBAs) has been discontinued, rocuronium is the
Seok Kyeong Oh, Byung Gun Lim
doaj   +1 more source

Sugammadex: clinical development and practical use [PDF]

open access: yesKorean Journal of Anesthesiology, 2013
Sugammadex is belonging to a new class of drugs: the selective relaxant binding agents. Sugammadex can reverse residual paralysis by encapsulating free circulating non depolarizing muscle relaxants.
Thomas Fuchs-Buder   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy